Answers are grounded in this paper and cite their sources.
Defects in the gastrointestinal tract, lymphatic system, and other fluid-conducting organs are exposed to bleeding, leakage, hypoxia, microbial contamination, and repeated mechanical loading. Conventional clips, powders, patches, and hydrogel sealants can close these defects but often do not correct local oxygen deficiency or inflammatory escalation during early healing. In this narrative review, the term erythrocyte-mimetic is reserved for systems that reproduce at least one defining red-blood-cell feature—hemoglobin-mediated reversible oxygen binding within a protective carrier, erythrocyte-like geometry or deformability, or membrane/cytoskeletal behavior. These core systems are distinguished from erythrocyte-inspired oxygen carriers, non-erythrocytic oxygen reservoirs, catalytic or biological oxygen generators, and supporting hemostatic or adhesive matrices. Evidence is graded from material-level and in vitro tubular studies through ex vivo organ, small-animal tubular, large-animal tubular, and clinical evidence; non-tubular studies are identified as adjacent evidence. Gastrointestinal repair is treated as the primary evidence-supported application, whereas lymphatic, biliary, pancreatic, urinary, and airway-like uses remain emerging extensions. For lymphatic defects, the intended target is peri-defect tissue oxygenation rather than oxygen carriage by lymph. Platform selection is evaluated together with wet adhesion and retention, hemostatic effectiveness, hemocompatibility where blood contact occurs, degradation, obstruction risk, and organ-specific repair. Most available studies remain material-level or adjacent, and direct evidence for integrated erythrocyte-mimetic oxygenating sealants in dynamic tubular—and especially lymphatic—repair is limited. An indication-first, author-proposed translational roadmap therefore prioritizes quantitative oxygen-interface measurements, dynamic-flow retention, failure analysis, manufacturing quality attributes, and prospective organ-relevant validation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: